Delivery Order SPE2DR25D2101-SPE2DR26F46RA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $2,167.44. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of December 18, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract structure. The delivery order, valued at $1,452.53, is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 20 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,586.45 under a firm fixed-price delivery order arrangement, with an ultimate completion date of December 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,415.15. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,508.14. This non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract ceiling value of $3,433.81. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,718.96 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on December 16, 2025, with completion scheduled for December 17, 2025. This non-competitive, firm fixed-price delivery order represents pharmaceutical procurement for military healthcare needs, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,097.69. This non-set-aside delivery order is scheduled for completion by December 10, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 10 mg capsules (100-count) with a ceiling value of $2,177.29. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order is scheduled for completion by December 9, 2025, with performance originating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,015.70. This is a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46RADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Adderall XR 20 mg capsules (100 count) valued at $1,445.10, with an ultimate completion date of December 19, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor for the Defense Logistics Agency's medical supply chain, which serves military healthcare systems, the Defense Health Agency, and other federal healthcare organizations. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive capabilities to supply a comprehensive range of brand-name and generic medications, specialty drugs, and medical supplies across multiple therapeutic domains. The underlying IDC vehicle positions the company as a primary source for pharmaceutical procurement to support military health programs globally, with the DLA currently planning Generation V Pharmaceutical Prime Vendor Global Program contracts that may involve multiple regional awards across additional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/17/25 |